semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Abdominal Pain Abdominal Myofascial Pain Syndrome (AMPS) Abdominal Plane Blocks (APB) All patients aged over 18 years. 2. Chronic abdominal pain for above 6 months 3. Moderate to severe pain in the abdomen: Baseline NRS >4 (worst pain the last 24 hours)  Lack of consent, including from those patients who lack mental capacity to give informed consent. 2. Patients with known history of drug allergy to depomedrone 3. Patients with infection at injection site at on day of treatment
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Cholangitis Adult patients (age >18 years) with acute cholangitis Admitted in Intensive care units With a successful biliary drainage And treated with antibiotics  patients under 18 years unable to receive a drainage or inefficient drainage Patients with a decision to limit care at the admission pregnancy
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Endocarditis, Bacterial Definite IE, according to modified ESC 2015 caused by gram-positive cocci (staphylococci, streptococci and enterococci), including native, prosthetic valve IE and cardiac device-related IE years old or older Patients treated for at least 10 days of appropriate parenteral antibiotic therapy overall (according to guidelines and microbiology sensitivity testing), and at least 7 days of parenteral antibiotic therapy after valve surgery when indicated Absence of fever, microbiological or analytical findings suggesting persistent infection at randomization Absence of locally uncontrolled infection signs (abscess, pseudoaneurysm, fistula, enlarging vegetation) at randomization, confirmed by recent transesophageal echocardiography (performed within 48 h of randomization) Women of childbearing potential who will agree to the use of effective contraceptive methods while on antibiotic treatment  Patients who have received appropriate parenteral antibiotic therapy for infective endocarditis for more than 12 days Patients not suitable to be discharged after 10 days of conventional treatment, due to clinical reasons (sequels of stroke that prevent discharge, progressive renal failure, hepatic failure) Patients receiving chemotherapy or immunosuppressive therapy Pregnant or breastfeeding women Need of prolonged antibiotic therapy due to spondylodiscitis or other septic complication Absence of patient's ability or commitment to continue follow-up after being discharged from hospital Inability to give informed consent to participation Cognitive impairment or lack of language skills needed to complete the questionnaires Patients who meet urgent cardiac surgery ESC but are considered inoperable due to high surgical risk
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 15.0-49.0,  Infertility, Female Pelvic Inflammatory Disease Women who present for hysterosalpingography as routine work up for infertility  Women who present for hysterosalpingography for other indications apart from infertility Women with history of use of antibiotics within two weeks of the procedure Women with symptoms of acute pelvic infection
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Diarrhea Acute Colitis of Presumed Infectious Origin for patients presenting an acute diarrhoea : 1. Patients over 18 years of age, 2. Signed informed consent form 3. Having a social security insurance, 4. Attending the emergency department for Acute diarrhoea (at least three loose or liquid stools a day for less than 15 days) 5. For whom a blood test in the emergency department is ordered as a standard of care for patients presenting an infectious colitis : 1. Patients over 18 years of age, 2. Signed informed consent form 3. Having a social security insurance, 4. Attending the emergency department for a documented colitis presumed to be of infectious origin, for whom a blood test in the emergency department is planned, defined by: 1. at least one of the following symptoms: abdominal pain, fever, diarrhoea and 2. Elevated white blood cell count (> 10.000/mm3) or CRP (> 10 mg/l) and 3. An abdominal CT scan showing a thickening of at least segmental colonic walls  Recent abdominal surgery of less than one month 2. Pregnancy 3. Inflammatory bowel disease 4. Patients under curatorship or guardianship
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Implementation Science Delirium Intensive Care Unit Acquired Weakness Pain Sedation Complication Mechanical Ventilation Complication ICU patient who was enrolled in ICU Liberation Collaborative (preexisting data) ICU provider or organization who participated in ICU Liberation Collaborative (preexisting data) ICU provider who was responsible for bundle implementation efforts associated with SCCM ICU Liberation Collaborative (prospective collected data)  Did not participate in ICU Liberation Collaborative efforts
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Stroke Age 18 years old Stroke event occurred at least 6 months ago Observable gait deficits Able to walk without the support of another person for at least 2 minutes (with or without an assistive device or orthotic support) Passive ankle dorsiflexion range of motion to neutral with the knee extended (i.e., able to achieve an angle of 90 degrees between the shank and the foot) Resting heart rate between 40 bpm, inclusive Resting blood pressure between 90/60 and 170/90 mmHg, inclusive Medical clearance by a physician  Score of >1 on question 1b and >0 on question 1c on the NIH Stroke Scale Inability to communicate with investigators Neglect or hemianopia Unexplained dizziness in the last 6 months Pressure ulcers or skin wounds located at human-device interface sites History of significant Peripheral Artery Disease (PAD) Unresolved Deep Vein Thrombosis (DVT) Uncontrolled or untreated hypertension Significant paretic ankle contractures (plantarflexion > 5°) Psychiatric or cognitive impairments that may interfere with proper operation of the device
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 19.0-999.0,  Abdominal Pain Patient presenting to the MGH Emergency Department with abdominal pain English-speaking  Known to be pregnant Patients with altered mental status Patients who are critically ill or unstable
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Clostridium Difficile Infection Diagnosed of C. difficile infection 2. Age older than 18 years old  Failing to meet the 2. If the positive microbiological results were not associated with clinical features of gastrointestinal infection. 3. Patients with incomplete data
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 3.0-12.0,  Autistic Spectrum Disorder Is not allergic to Dates (tested initially by one piece of Dates) Agrees to the intake of Dates fruits for at least 3 months Not participating in another study Signed the consent to participate in the study Caregiver consent was obtained for all the studied cases  All subjects with other causes of mental sub-normality and/or delayed language Refuses intake of Dates Participating in another study Refused to sign the consent to participate in the study Patients who consumed probiotics and/or Dates for at least 4 weeks prior to the trial and/or antibiotics or laxatives for 6 months prior to the start
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Terminal Care patients The patient is aware that recovering from his/her disease is unlikely, to be assessed by the attending physician The attending physician would not be surprised if the patient were to die within 6 months If the physician is uncertain about the surprise question, the patient is eligible if presenting with at least one SPICT indicator: General SPICT indicators Unplanned hospital admission Performance status is poor or deteriorating, with limited reversibility (eg stays in bed or in a chair for more than half the day) Depends on others for care due to increasing physical and/or mental health problems; person's carer needs more help and support Progressive weight loss; remains underweight; low muscle mass Persistent symptoms despite optimal treatment of underlying condition(s) Person (or family) asks for palliative care; chooses to reduce, stop or not have treatment; or wishes to focus on quality of life Disease-specific SPICT indicators: Cancer  patients The patient is incapable of filling in a questionnaire in the country's main language or in English (patients may be supported by relatives when filling in the questionnaire) The patient is incapable of providing informed consent to participate in the study, to be assessed by the attending physician relatives Family, friend or other close relative of the patient years or older The relative is aware that it is unlikely that that patient will recover from his/her disease relatives The relative is incapable of filling in a questionnaire in the country's main language or in English The relative is incapable of providing informed consent to participate in the study
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Sepsis Cardiac Arrest Pneumonia Abdominal Sepsis SIRS for community-acquired Sepsis and Septic Shock 1. Age => 18 2. Admission to hospital within 72 hours of symptoms onset and development of clinical signs of sepsis 3. Diagnosis of sepsis is defined as a (1) FOCUS OF AND (2) SOFA>2, with at least ONE organ specific SOFA subscore =2. 1. (1) FOCUS OF is indicated by either i. An organism grown in blood or sterile site OR ii. An abscess or infected tissue (e.g. pneumonia, peritonitis, urinary tract, vascular line infection, soft tissue, etc). 2. (2) The SOFA score are described in the Appendix [7] SHOCK is defined as plus the presence of hypotension requiring the use of vasopressors to maintain mean arterial pressure of 65 mmHg or greater and having a serum lactate level greater than 2 mmol/L persisting after adequate fluid resuscitation [8] for Critically Ill patients without infection 1. Patients admitted to the ICU following out-of hospital cardiac arrest OR Patients admitted to the ICU following major trauma (ISS>12) OR Patients admitted to the ICU following pancreatitis 2. Have multiorgan failure as defined by SOFA>2, with at least ONE organ specific SOFA subscore =2. 3. Patients must not be receiving antibiotics for treatment of known or suspected infection 4. patient already has or will require arterial cannulation as part of standard treatment  Patients who are on immune-modulating therapy (e.g., methotrexate, prednisolone >5mg/day, or other immunosuppressants) for any length of time within 6 months of index admission 2. Patients with acquired cellular immune deficiency (E.g. active HIV infection or AIDS); 3. Patients with concurrent blood-borne viral infections (E.g. Hepatitis B or C) 4. Patients with any haematological malignancy in their past medical history; 5. Patients who are on chronic haemodialysis; 6. Solid organ transplant recipients; 7. Patients who have biopsy, image or endoscopy proven liver cirrhosis; 8. Patients who are not expected to survive beyond 90 days due to the advancement of their underlying disease
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 0.0-22.0,  Acute Myeloid Leukemia All patients must be enrolled on APEC14B1 and consented to Screening (Part A) prior to enrollment and treatment on AAML1831. Submission of diagnostic specimens must be done according to the Manual of Procedures). Risk stratification will not be possible without the submission of viable samples. Given there are multiple required samples, bone marrow acquisition techniques such as frequent repositioning or performing bilateral bone marrow testing should be considered to avoid insufficient material for required studies. Consider a repeat marrow prior to starting treatment if there is insufficient diagnostic material for the required studies Patients must be less than 22 years of age at the time of study enrollment Patient must be newly diagnosed with de novo AML according to the 2016 World Health Organization (WHO) classification with or without extramedullary disease Patient must have 1 of the following >= 20% bone marrow blasts (obtained within 14 days prior to enrollment) In cases where extensive fibrosis may result in a dry tap, blast count can be obtained from touch imprints or estimated from an adequate bone marrow core biopsy < 20% bone marrow blasts with one or more of the genetic abnormalities (sample obtained within 14 days prior to enrollment) A complete blood count (CBC) documenting the presence of at least 1,000/uL (i.e., a white blood cell [WBC] count >= 10,000/uL with >= 10% blasts or a WBC count of >= 5,000/uL with >= 20% blasts) circulating leukemic cells (blasts) if a bone marrow aspirate or biopsy cannot be performed (performed within 7 days prior to enrollment) ARM C: Patient must be >= 2 years of age at the time of Late Callback ARM C: Patient must have FLT3/ITD allelic ratio > 0.1 as reported by Molecular Oncology  Patients with myeloid neoplasms with germline predisposition are not eligible Fanconi anemia Shwachman Diamond syndrome Patients with constitutional trisomy 21 or with constitutional mosaicism of trisomy 21 Any other known bone marrow failure syndrome Any concurrent malignancy Juvenile myelomonocytic leukemia (JMML) Philadelphia chromosome positive AML Mixed phenotype acute leukemia Acute promyelocytic leukemia
Patient description: The patient is a 60-year-old woman admitted to the stroke department with a recent history of a second course of intravenous antibiotics for aspiration pneumonia. She is febrile and complained of abdominal pain and diarrhea (bowel movements eight times in 3 hours, large volumes of greenish, liquid stool each time). The patient's abdomen is generally tender and distend with hyperactive bowel sounds. She is febrile (38.4°C), tachycardic (113/min) and hypotensive (80/40 mmHg). The stool samples must were positive for Clostridium difficile toxin.

Clinical trial eligibility criteria: eligible ages (years): 65.0-110.0,  Clostridioides Difficile Infection Clostridium Difficile Infection Clostridium Difficile Diarrhea Clostridia Difficile Colitis Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. Male or female, aged > 65 years 4. Admitted in the hospital 5. Presence of diarrhea* 6. Stool positive for C. difficile tcdB and TcdB 7. 1st episode of C. difficile infection, non-severe or severe uncomplicated 8. Within 48 hours of receiving standard therapy (oral vancomycin at UVA)  At enrollment, presence of any of the following Hypotension or shock Megacolon or moderate to severe ileus Acute abdomen Admission to intensive care unit 2. Inability to tolerate oral or enteral medication 3. Presence of other known infectious etiology of diarrhea 4. Inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis) or other etiology of non-infectious diarrhea 5. Enrollment in another investigational drug trial 6. Current use of alternative treatment for CDI (e.g. antibiotics other than vancomycin or fidaxomicin; IVIg; fecal transplant). 7. On probiotics and not willing to discontinue. 8. Cirrhosis or in participants with ALT > 3X normal 9. End stage renal disease, on dialysis, or creatinine clearance or estimated GFR of <30mL/min even after adequate hydration 10. Life expectancy of < 6 months